ChIP-Chip Protocols & Methods

 

 

Chromatin Immunoprecipitation Protocol

 

Cell harvest and crosslinking complexes in vivo:

  1. Grow cells to confluence in TC flask. Plate 1.552x107 for BMM in T-150.
  2. Stim cells
  3. Save approximately 1ml supe for ELISA, store at -20°C.
  4. Wash cells with 20mL room temperature PBS (Cellgro).
  5. Add 20mL of PBS to cells, and then add 540uL of formaldehyde stock solution (37% Fisher #F79-500). Final concentration is 1%. Incubate for exactly 5 min at room temperature, occasionally mixing flasks.
  6. Add 1.7mL of 1.5M glycine to stop the crosslinking reaction (final concentration is 0.125 M).
  7. Incubate 5 min at room temperature, occasionally mixing flasks.
  8. Wash 3 x 1.5 min with 20mL ice-cold PBS.
  9. Add 20mL of ice cold PBS and scrape cells. Rinse with an additional 10mL PBS. Add to 50mL conical tube and centrifuge at 1500 rpm at 4°C for 5 min. Remove supernatant. Store cell pellets at -80°C.

Cell lysis and chromatin sonication:

  1. Resuspend cell pellet in 750ul RIPA plus 7.5ul protease inhibitors for probe sonicator (500uL of RIPA buffer plus 5uL protease inhibitors for UCD-200). (Calbiochem Inhibitor cocktail 1 #539131, 100x stock).
  2. Leave cells on ice for 30 min with occasional vortexing.
  3. Disrupt cells by drawing through a 30g needle 3X, put into 1.5ml tube (or 15 ml conical BD Falcon #352095 if using UCD-200).
  4. Leave cells on ice for an additional 30 min.
  5. Save 25ul of pre-sonicated sample, do not centrifuge.
  6. Sonicate: Wear Hearing Protection!
  1. Transfer supernatant to new tube (store chromatin samples at -80°C).
  2. Save 25ul of sonicated sample to check sonication.


Check Sonication:












Protein Concentration: Perform BioRad DC Protein assay on chromatin samples to determine protein concentration. Use Microplate assay protocol.

*note: The BSA used for protein assay is different than the BSA used for different steps in the IP and amplification.


Sample preclearing and immunoprecipitation: Dilute samples (1ml final volume) to 0.5mg/ml for BMM.

For ChIP-chip: make an additional 60ul of 0.5mg/ml for BMM to use as real input chromatin controls: final volume = 1.06ml. Pull out 60ul and qs to 250ul with RIPA and set aside to reverse the crosslinks in step 29. Use the remaining 1ml for the next step:

  1. Sample preclearing: Add 30uL of Salmon sperm DNA/protein-A agarose beads (Upstate #16-157), use large bore pipet tips. Incubate for 15 min with end over end mixing at 4°C.
  2. Spin tubes at 7500 rpm for 2 min.
  3. Transfer supernatant to new tube, discard beads.
  4. Add antibody (concentration of antibody must be empirically determined) and 10ul BSA in 10X TBS (#37520 Pierce) to supernatant.
  5. Incubate overnight at 4°C with end over end mixing; put on parafilm to prevent leaking or evaporation.
  6. Add 70uL of Salmon sperm DNA/protein-A agarose beads. Incubate 30 min at 4°C with end over end mixing.
  7. Spin tubes at 3000 rpm for 3 min.
  8. Carefully remove the supernatant (try not to disturb the beads) Keep the beads!!!!!
  9. Wash the beads for 5 min at RT with end over end mixing with 1mL of the following buffers. Spin tubes at 3000 rpm for 3 min after every wash to pellet the beads.
  1. Extract immunoprecipitates by adding 100uL of 1% SDS in TE to the beads. Mix and incubate the samples at 65°C for 15 min (in water bath). Spin tubes at 3000 rpm for 3 min, transfer eluate to fresh tube and wash beads with a further 150uL of 1% SDS in TE as above (incubate for 15 min at 65°C in water bath). Respin and add to first eluate. Save the eluates... the beads are no longer attached to what we want.

Reversal of crosslinks and final DNA purification:

  1. Add 15uL of 4M NaCl to each sample including input controls (Tv=265uL).
  2. Incubate the samples for > 5 hr at 65°C.
  3. Vortex samples, then to each tube add:
  1. Incubate >1 h at 42°C. Remove phenol:chloroform:isoamyl alcohol from fridge and let it warm to room temperature.
  2. In the hood: Add an equal volume (282.5ul) of phenol:chloroform:isoamyl alcohol (25:24:1 Fisher #BP1752-100). Draw from the lower phase.
  3. Vortex tubes and spin tubes at 4000 rpm for 5 min.
  4. Remove 240ul aqueous (upper) phase.
  5. In the hood: Add 240ul of Chloroform:isomyl alcohol (24:1) to aqueous phase.
  6. Vortex tubes and spin tubes at 4000rpm for 5 min.
  7. Remove 220ul of aqueous phase.
  8. To aqueous phase add:
  1. Let stand 5 min at room temperature.
  2. Spin at 13,000 rpm for 10 minutes.
  3. Discard the supernatant and wash pellet with 440uL 70% EtOH.
  4. Remove supernatant and air dry the pellet.
  5. Resuspend DNA in 30uL of molecular grade water and store at -20°C.

Solutions: All solutions are made with Millipore water and should be steri-flipped or autoclaved prior to use. Always wear gloves and a lab coat and rinse all glassware with Millipore water prior to use.

1.5M glycine: 75.1 MW x final volume (in Liters) x 1.5M = grams of glycine

3M Sodium Acetate pH 5.2: Dissolve 408.3g of sodium acetate-3H20 in 800 ml of H20.

10% SDS: Wear a mask!! Dissolve 10g of electrophoresis-grade SDS in 75mL H20.

Heat to 68°C and stir to dissolve. Adjust pH to 7.2 with HCl if necessary. Final

volume is 0.1L. Do not autoclave!

RIPA Buffer - final volume is 50mL

TE Buffer - final volume is 50 mL

1xRIPA Buffer with 1M NaCl - final volume is 100mL

LiCl Buffer - final volume is 100mL

(2xRIPA with NaCl and LiCl buffers are from V.A. Spencer et.al. METHODS 31 (2003) 67-75.)


Primer A2 HPLC Purified PCR (adapted from Affymetrix protocol):












Fragment Samples:




TdT Labeling:




 

 

 

ChIP-Chip Data Analysis Methods

Two different 25-mer Affymetrix GeneChip® oligonucleotide microarrays were used for the ChIP-chip analysis. One was a custom array, which densely tiled 20 kb upstream and 20 kb downstream (and selectively, the coding regions) of genes chosen based on differential expression in preliminary microarray studies using murine RAW 264.7 cells stimulated for 60 minutes by LPS, Pam3CSK4, or Pam2CSK4. The other was the Affymetrix mouse promoter array. Hybridization and scanning of the custom tiling array was carried out using standard protocols and reagents from Affymetrix.

Analysis of the ChIP-chip data was carried out using Model-based analysis of tiling arrays (MAT), after first mapping the microarray probes to the NCBI Build 37 mouse genome assembly (mm9, July 2007), and filtering out probes that mapped to repeat regions. Probes mapping to multiple locations were excluded from all analysis. Retained probe sequences were then checked for potential overlaps with regions of repeat sequences. Tables of repeats identified by RepeatMasker and those termed simple repeats were downloaded from the UCSC mouse genome annotation browser for the July 2007 assembly. Probe sequences overlapping with a repeat region by at least a single nucleotide were also excluded from all analysis. The filtered probe mappings were then used to create custom BPMAP files for use with MAT.

MAT was run in a hierarchical manner utilizing both "multiple replicates of ChIP-chips and controls" and "single replicates of ChIP-chips/multiple replicates of controls" scenarios to efficiently identify enriched segments that were consistent across biological replicates. For most antibodies and conditions, three biological replicate experiments were performed. To illustrate our approach, take as an example analysis of the binding of transcription factor PU.1 in bone-marrow derived macrophages stimulated with LPS for 4hrs. Three independent ChIP-chip biological replicate experiments investigating PU.1 binding in macrophages stimulated with LPS for four hours were performed, which, after ChIP, DNA fragmentation, labeling, hyrbridization, etc, produced three CEL files. These three CEL files were analyzed together using MAT in the "multiple replicates of ChIP-chips and controls" scenario. For controls, we used our database of negative control CEL files for ChIP experiments using normal rabbit serum (NRS) in place of an antibody. For the custom tiling array, we have 30 NRS ChIP-chip CEL files, for the Affymetrix promoter array, we have 10 NRS ChIP-chip CEL files. MAT analysis parameters were set to their default values (intensity analysis: BandWidth = 300, MaxGap = 300, MinProbe = 10, Tvalue = 0), and segments with P-values less than 0.2 were retained for downstream processing. Running the three PU.1 ChIP-chips in comparison to the NRS ChIP-chips using MAT generates an output file (.bed.xls) of enriched segments and their associated MAT scores. In our experience, these enriched segments obtained from a "replicate combined" type of analysis generally constitute a superset of segments that would be identified from running the replicates individually with MAT. Thus, a segment being enriched in this analysis does not imply that the segment is consistently enriched across all replicates.

To address the issue of replicate consistency, we also run each of the individual PU.1 CEL files in comparison to the negative control set of ChIP-chips, giving rise to three .bed.xls files with enriched segments for each individual replicate. We also run each of the individual NRS CEL files in comparison to the complete set of negative control NRS CEL files. We then go back to the original .bed.xls file from the replicate combined analysis and find the MAT scores for the segments in the individual replicates that overlap. We then take these MAT scores from the mapping and perform a simple one-sided t-test to identify segments that have statistically significantly higher MAT scores for PU.1 than the negative control NRS ChIP-chips. Given the possibility for outlier ChIP-chips, we also perform the analysis using all possible subset pairs of ChIP-chips for the antibody, and retain the enrichment statistics for the best combination. In this manner, we identify both "high confidence" (enriched segments consistent across all three replicates) and "moderate confidence" (enriched segments consistent across at least two biological replicates) segments. Empirically defined thresholds for reporting segments are: MAT > 1.4 (for replicate combined .bed.xls file from which candidate enriched segments are selected), p < 0.05 (for t-test comparing segments across replicates), and ΔMAT (difference between average of PU.1 MAT scores and NRS MAT scores) > 0.8. Figures illustrating our overall approach are shown below.


Click to see a larger image.


Click to see a larger image.